Home › Funds › Cormorant Asset Management, LP › CRBP

Cormorant Asset Management, LP position in CRBP

CORBUS PHARMACEUTICALS HLDGS · Health Care

Cormorant Asset Management, LP reported holding 2,344,971 shares of CRBP (CORBUS PHARMACEUTICALS HLDGS) in its Q3 2026 13F filing — a position valued at US$16.0M, representing 1.14% of its reported portfolio and ranking #28 among its reported holdings. Cormorant Asset Management, LP has disclosed CRBP holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)2.34M sh
Reported value held$15.99M
Portfolio Weight1.14%
First reportedQ1 2024
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's CRBP position evolved

Cormorant Asset Management, LP first disclosed a stake in CRBP in Q1 2024 at 2,025,000 shares (US$79.5M). The position peaked in Q2 2024 at 2,025,000 shares, worth US$91.6M. Across 11 filings, Cormorant Asset Management, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 2,344,971 shares valued at US$16.0M.

Quarter by quarter

QuarterSharesValueChange
Q1 2024 2.02M $79.46M New
Q2 2024 2.02M $91.63M Hold
Q3 2024 2.38M $49.00M Add
Q4 2024 2.38M $28.02M Hold
Q1 2025 2.38M $12.61M Hold
Q2 2025 2.38M $16.39M Hold
Q3 2025 2.38M $30.04M Hold
Q4 2025 2.34M $19.09M Reduce
Q1 2026 2.34M $22.02M Hold
Q2 2026 2.34M $22.00M Hold
Q3 2026 2.34M $15.99M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRBP and 13F data

CRBP (CORBUS PHARMACEUTICALS HLDGS) is a Health Care company. 25 other funds we track also report a position in CRBP — the largest reported positions include MPM BioImpact LLC (US$11.4M), Jones Hill Capital LP (US$6.0M), DIADEMA PARTNERS LP (US$5.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRBP

All CRBP fund holders →

FAQ

How long has Cormorant Asset Management, LP held CRBP?

Cormorant Asset Management, LP has disclosed CRBP holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Cormorant Asset Management, LP's current position in CRBP?

As of Q3 2026, Cormorant Asset Management, LP holds 2.34M shares of CRBP (CORBUS PHARMACEUTICALS HLDGS), valued at $15.99M, representing 1.14% of its reported portfolio and ranking #28.

Has Cormorant Asset Management, LP been buying or selling CRBP?

In the latest 13F filing (Q3 2026), Cormorant Asset Management, LP held unchanged its position in CRBP. The position peaked in Q2 2024 at 2.02M shares.

Which other funds hold CRBP?

Other major institutional holders of CRBP include MPM BioImpact LLC, Jones Hill Capital LP, DIADEMA PARTNERS LP, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.